目的 了解住院患者藥疹的情況和重癥藥疹的皮疹特點(diǎn)，并對(duì)此提出藥學(xué)監(jiān)護(hù)分析建議。方法 回顧性分析2011年—2012年新疆維吾爾自治區(qū)人民醫(yī)院收治確診藥疹的患者169例，了解住院患者藥疹的情況和重癥藥疹的皮疹特點(diǎn)，并對(duì)此提出藥學(xué)監(jiān)護(hù)分析建議。結(jié)果 本次調(diào)查藥疹致敏藥物主要構(gòu)成為抗菌藥物類（占45.56%）、中藥類（占24.85%）、解熱鎮(zhèn)痛類藥物（占15.98%）；藥疹疹型主要構(gòu)成為蕁麻疹型（43.79%）、發(fā)疹型（19.53%）、多形紅斑型（13.02%）。結(jié)論 抗菌藥物類和中藥類是藥疹的主要致敏藥物，建議臨床醫(yī)務(wù)人員應(yīng)詳細(xì)詢問(wèn)患者用藥史，發(fā)生皮疹時(shí)應(yīng)及時(shí)停用可疑致敏藥物，并加強(qiáng)對(duì)皮疹的藥學(xué)監(jiān)護(hù)工作。

Objective To investigate the clinical feature of inpatients with drug eruption and explore the pharmaceutical care of those inpatients. Methods A retrospective analysis was carried out on the clinical data of 169 drug eruption cases from 2011 to 2012. Results The composition of causative drugs was antimicrobial drugs (45.56%), Chinese materia medica (CMM, 24.85%), and antipyretic analgesic (15.98%). The composition of clinical manifestation was urticaria type (43.79%), exanthesis type (19.53%), and rash erythematous type (13.02%). Conclusion The major involved drugs inpatients with drug eruption are antimicrobial drugs and CMM. It is necessary for the medical staff to know the drug-used history of inpatients and to stop using questionable allergize drugs promptly, at the same time, to receive the pharmaceutical care provided by clinical pharmacists.